Article info

Download PDFPDF
Extended report
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

Authors

  1. Correspondence to Dr Salvatore De Vita, Department of Medical and Biological Sciences, Rheumatology Clinic, University Hospital ‘Santa Maria della Misericordia’, Udine 33100, Italy; devita.salvatore{at}aoud.sanita.fvg.it
View Full Text

Citation

Quartuccio L, Fabris M, Pontarini E, et al
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

Publication history

  • Received July 31, 2012
  • Revised February 2, 2013
  • Accepted February 24, 2013
  • First published March 16, 2013.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.